Stocks
GDR MD Medical Group Inv. PLC Financial Statements (MDMG) |
||||||||||
| Мать и Дитя (MD)smart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 12.09.2023 | 30.10.2023 | 01.04.2024 | 01.04.2024 | ||||||
| Currency | RUB | RUB | RUB | RUB | RUB | RUB | ||||
| Financial report URL | ||||||||||
| Presentation URL | ||||||||||
| Revenue, bln rub | ? | 6.22 | 6.63 | 6.79 | 7.99 | 27.6 | ||||
| Operating Income, bln rub | 3.27 | 4.24 | 7.51 | |||||||
| EBITDA, bln rub | ? | 4.10 | 5.12 | 9.22 | ||||||
| Net profit, bln rub | ? | 3.37 | 4.45 | 7.82 | ||||||
| Net profit not adj., bln rub | ? | 3.37 | 3.37 | |||||||
| OCF, bln rub | ? | 4.37 | 5.01 | 9.38 | ||||||
| CAPEX, bln rub | ? | 1.95 | 1.63 | 3.58 | ||||||
| FCF, bln rub | ? | 2.51 | 3.49 | 6.00 | ||||||
| Dividend payout, bln rub | 10.6 | 10.6 | ||||||||
| Dividend, rub/share | ? | 141 | 141 | |||||||
| Ordinary share dividend yield, % | 0.0% | 0.0% | 0.0% | 0.0% | 14.2% | 13.2% | ||||
| Dividend payout ratio, % | 0% | 0% | 135% | |||||||
| OPEX, bln rub | 1.69 | 2.08 | 3.77 | |||||||
| Cost of production, bln rub | 7.89 | 8.45 | 16.3 | |||||||
| Assets, bln rub | 36.4 | 41.3 | 41.3 | |||||||
| Net Assets, bln rub | ? | 30.2 | 34.6 | 34.6 | ||||||
| Debt, bln rub | 0.640 | 0.876 | 0.876 | |||||||
| Cash, bln rub | 6.65 | 9.89 | 9.89 | |||||||
| Net debt, bln rub | 0.00 | -6.01 | 0.00 | -9.02 | 0.00 | -9.02 | ||||
| Ordinary share price, rub | 534.6 | 632.6 | 842.8 | 775.3 | 990.0 | 1 072 | ||||
| Number of ordinary shares, mln | 75.1 | 75.1 | 75.1 | 75.1 | 75.1 | 75.1 | ||||
| Market cap, bln rub | 40.2 | 47.5 | 63.3 | 58.2 | 74.4 | 80.5 | ||||
| EV, bln rub | ? | 40.2 | 41.5 | 63.3 | 49.2 | 74.4 | 71.5 | |||
| Book value, bln rub | 0.00 | 28.2 | 0.00 | 34.6 | 0.00 | 34.6 | ||||
| EPS, rub | ? | 0.00 | 44.9 | 0.00 | 59.3 | 0.00 | 104.1 | |||
| FCF/share, rub | 0.00 | 33.4 | 0.00 | 46.5 | 0.00 | 79.9 | ||||
| BV/share, rub | 0.00 | 375.9 | 0.00 | 459.9 | 0.00 | 459.9 | ||||
| EBITDA margin, % | ? | 0.0% | 61.8% | 0.0% | 64.1% | 33.4% | ||||
| Net margin, % | ? | 0.0% | 50.8% | 0.0% | 55.8% | 28.3% | ||||
| FCF yield, % | ? | 16.1% | 14.0% | 10.5% | 10.3% | 8.1% | 7.5% | |||
| ROE, % | ? | 23.1% | 22.6% | 22.6% | ||||||
| ROA, % | ? | 19.2% | 18.9% | 18.9% | ||||||
| P/E | ? | 6.69 | 6.81 | 9.07 | 7.45 | 9.51 | 10.3 | |||
| P/FCF | 18.9 | 9.71 | 12.4 | 13.4 | ||||||
| P/S | ? | 1.59 | 1.83 | 2.41 | 2.11 | 3.47 | 2.91 | |||
| P/BV | ? | 1.68 | 1.69 | 2.33 | ||||||
| EV/EBITDA | ? | 5.07 | 4.90 | 7.48 | 5.34 | 8.07 | 7.76 | |||
| Debt/EBITDA | 0.00 | -0.71 | 0.00 | -0.98 | 0.00 | -0.98 | ||||
| Employees, people | 8 413 | 8 805 | 8 805 | |||||||
| Expenses per employee, thousand rub | 0.00 | 0.00 | 0 | |||||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0 | |||||||
| CAPEX/Revenue, % | 0% | 29% | 0% | 20% | 13% | |||||
| GDR MD Medical Group Inv. PLC shareholders | ||||||||||
